ArticleScientific reports2025
Orobanche aegyptiaca-chitosan nanocomposite efficacy against the freshwater snail Biomphalaria alexandrina.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Biocontrol potential ofParasite epidemiology and control · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As one of the neglected tropical diseases, schistosomiasis is responsible for various social and economic issues in numerous developing countries. The intermediate host of Schistosoma mansoni is the Biomphalaria alexandrina snails. A promising approach to mitigate the transmission of this disease is to use medicinal plants loaded with nanomaterials to control these snails. This research aimed to investigate the molluscicidal activity of Orobanche aegyptiaca- chitosan nanocomposite on B. alexandrina snails. The phytochemical screening of the tested plant verified its abundance of saponins, tannins, and flavonoids, which may be responsible for its cytotoxic effects. Chitosan nanoparticles were produced using the ionotropic gelation technique, while the O. aegyptiaca-chitosan nanocomposite was synthesized using the sonochemical approach. The characterization of the nanocomposite was carried out using TEM, XRD, and Zeta potential. The results demonstrated that the survival, fecundity (eggs/snail/week), and reproductive rates of B. alexandrina snails were substantially reduced upon exposure to the sub-lethal concentrations LC10 or LC25 of O. aegyptiaca-chitosan nanocomposite. Biochemically, it adversely affected some parameters, where it considerably (P < 0.05) raised ALT, AST, and ALP levels, while urea, uric acid, and cholesterol were significantly decreased compared to control snails. Furthermore, the antioxidant markers CAT, SOD, and GSH exhibited a substantial (P < 0.05) reduction, while MDA and NO levels increased at both sublethal concentrations. Histopathological examinations of the digestive gland of the treated B. alexandrina revealed a decrease in the size of the tubules, and the digestive and secretory cells degenerated. The hermaphrodite glands exhibited substantial damage in the reproductive tubules, with extensive damage to the gonadal cells, resulting in the loss of ova and sperm shapes. Also, the comet analysis showed a genotoxic effect of the nanocomposite, evidenced by significant changes in crucial comet assay parameters: tail length (TL), tail DNA percentage (TD), tail moment (TM), and olive tail moment (OTM). Conclusively, these findings confirmed the potential activity of O. aegyptiaca- chitosan nanocomposite as a molluscicidal agent against B. alexandrina to decrease schistosomiasis transmission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.